Literature DB >> 11027499

Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages.

A Breton1, A Descoteaux.   

Abstract

Phagocytosis of IgG-opsonized particles by macrophages requires the activation of protein kinase C (PKC), a family of protein serine/threonine kinases. In the present study, we have investigated the role of the PKC-alpha isoenzyme in FcgammaR-mediated phagocytosis using clones of the mouse macrophage cell line RAW 264. 7 overexpressing a dominant-negative (DN) mutant of PKC-alpha. Overexpression of DN PKC-alpha had no effect on the attachment of IgG-opsonized sheep red blood cells, but inhibited their internalization. Further analysis of the signaling events induced by IgG-opsonized sheep red blood cells revealed that whereas tyrosine phosphorylation of Syk was normal, phosphorylation of ERK 1/2 (p42/44) was impaired in DN PKC-alpha-overexpressing macrophages. These observations suggest a role for PKC-alpha in the regulation of FcgammaR-induced phagocytosis and signal transduction. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027499     DOI: 10.1006/bbrc.2000.3511

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

2.  Role of protein kinase C betaII in influenza virus entry via late endosomes.

Authors:  Sara B Sieczkarski; H Alex Brown; Gary R Whittaker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages.

Authors:  Jayati Mookerjee Basu; Ananda Mookerjee; Prosenjit Sen; Suniti Bhaumik; Pradip Sen; Subha Banerjee; Ksudiram Naskar; Soumitra K Choudhuri; Bhaskar Saha; Sanghamitra Raha; Syamal Roy
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 4.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Phagocytosis inhibits F-actin-enriched membrane protrusions stimulated by fractalkine (CX3CL1) and colony-stimulating factor 1.

Authors:  Yong Luo; Beth M Isaac; Arturo Casadevall; Dianne Cox
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

6.  Foreign body-type multinucleated giant cell formation requires protein kinase C beta, delta, and zeta.

Authors:  Amy K McNally; Sarah R Macewan; James M Anderson
Journal:  Exp Mol Pathol       Date:  2007-11-09       Impact factor: 3.362

7.  Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10.

Authors:  Andrew D Foey; Fionula M Brennan
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

8.  Activation of protein kinase C beta II by the stereo-specific phosphatidylserine receptor is required for phagocytosis of apoptotic thymocytes by resident murine tissue macrophages.

Authors:  Jill C Todt; Bin Hu; Antonello Punturieri; Joanne Sonstein; Timothy Polak; Jeffrey L Curtis
Journal:  J Biol Chem       Date:  2002-07-11       Impact factor: 5.157

9.  Differential regulation of protein kinase C isoforms of macrophages by pathogenic and non-pathogenic mycobacteria.

Authors:  Shivendra K Chaurasiya; Kishore K Srivastava
Journal:  Mol Cell Biochem       Date:  2008-07-24       Impact factor: 3.396

10.  Downregulation of protein kinase C-alpha enhances intracellular survival of Mycobacteria: role of PknG.

Authors:  Shivendra K Chaurasiya; Kishore K Srivastava
Journal:  BMC Microbiol       Date:  2009-12-24       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.